Qualigen Therapeutics, Inc.
General ticker "QLGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $20.5M (TTM average)
Qualigen Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -5.7%.
Estimated limits based on current volatility of 4.0%: low 2.28$, high 2.47$
Factors to consider:
- Total employees count: 4 as of 2023
- Top business risk factors: Strategic risks and growth management, Clinical trial success, Regulatory and compliance, Intellectual property risks, Labor/talent shortage/retention
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [9.69$, 45.03$]
- 2024-12-30 to 2025-12-30 estimated range: [3.81$, 19.60$]
Financial Metrics affecting the QLGN estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -7.14 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -103.46 <= 18.93
- Negative: negative Industry operating income (median)
Short-term QLGN quotes
Long-term QLGN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $5.65MM | $4.98MM | $0.00MM |
| Operating Expenses | $28.32MM | $22.93MM | $11.30MM |
| Operating Income | $-22.66MM | $-17.94MM | $-11.30MM |
| Non-Operating Income | $4.77MM | $-3.36MM | $-1.17MM |
| Interest Expense | $0.00MM | $0.03MM | $1.52MM |
| R&D Expense | $11.72MM | $6.84MM | $5.21MM |
| Income(Loss) | $-17.89MM | $-21.30MM | $-12.48MM |
| Taxes | $0.01MM | $-0.27MM | $-0.00MM |
| Other Income(Loss) | $0.00MM | $-7.14MM | $-1.29MM |
| Profit(Loss)* | $-17.90MM | $-21.03MM | $-13.42MM |
| Stockholders Equity | $16.56MM | $7.24MM | $-2.10MM |
| Inventory | $1.06MM | $1.59MM | $0.00MM |
| Assets | $22.84MM | $19.08MM | $2.03MM |
| Operating Cash Flow | $-14.73MM | $-13.25MM | $-10.30MM |
| Capital expenditure | $0.14MM | $0.32MM | $0.00MM |
| Investing Cash Flow | $-0.14MM | $-0.18MM | $4.22MM |
| Financing Cash Flow | $8.43MM | $2.91MM | $-0.55MM |
| Earnings Per Share** | $-6.10 | $-5.48 | $-2.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.